Last reviewed · How we verify
NCT05597774
Effects of Respiratory Muscle Training in Individuals With Long-term Post-COVID-19 Symptoms
NA trial testing Inspiratory + expiratory muscle training group in Covid19 in 64 participants. Completed in 22 September 2023.
22 September 2023
Quick facts
| Lead sponsor | Universidad Complutense de Madrid |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 64 |
| Start date | 28 October 2022 |
| Primary completion | 22 September 2023 |
| Estimated completion | 22 September 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Inspiratory + expiratory muscle training group
- Inspiratory + expiratory muscle training sham group
- Exercise training program
Conditions studied
- Covid19 — all drugs for Covid19 →
- Post-acute COVID-19 Syndrome — all drugs for Post-acute COVID-19 Syndrome →
Sponsor
Universidad Complutense de Madrid — full company profile →
Who can join
Adults 18 to 100, any sex, with Covid19 or Post-acute COVID-19 Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective of the present study is to observe the short-term effects of respiratory muscle training combined with an exercise training program on quality of life and exercise tolerance in individuals with long-term post-COVID-19 symptoms. As secondary objectives, the effects on respiratory muscle function, physical and lung function, as well as on the psychological state of these individuals.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of respiratory rehabilitation on quality of life in individuals with post-COVID-19 symptoms: A randomised controlled trial.
Del Corral T, Fabero-Garrido R, Plaza-Manzano G, Izquierdo-García J, et al · · 2025 · cited 6× · PMID 39798250 · DOI 10.1016/j.rehab.2024.101920
Verify or expand the search:
- PubMed search for NCT05597774
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Inspiratory + expiratory muscle training group
Trials testing the same drug.
- NCT04734561 — Effects of Respiratory Muscle Training in People Who Have Had COVID-19 Disease · NA · completed
Other recruiting trials for Covid19
Currently open trials in the same condition.
- NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
- NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
- NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
- NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
- NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting
Other Universidad Complutense de Madrid trials
Trials by the same sponsor.
- NCT07361848 — Long-Hold Yielding Isometric Exercise for Patellar Tendinopathy in Weightlifting Athletes · NA · not yet recruiting
- NCT07273006 — Percutaneous Electrical Nerve Stimulation As Alternative To Nerve Blocks In Anesthesia, Pain Medicine And Rehabilitation · Phase 4 · not yet recruiting
- NCT07527351 — ANALYSIS OF THE RELIABILITY AND VALIDITY OF LASER SPECKLE CONTRAST IMAGING · NA · recruiting
- NCT07484620 — Physical Activity and Fitness in Pediatric Inflammatory Bowel Disease · NA · not yet recruiting
- NCT07485400 — Aerobic Interval vs Continuous Training on Heart Rate-Power Decoupling in Ischemic Heart Disease · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05597774 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Complutense de Madrid
- Last refreshed: 28 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05597774.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing